ARTICLE | Clinical News
VX-366 small molecule transcription regulator that maintains activation of the fetal gene for hemoglobin F: BASFs Italian subsidiary, Ravizza Farmaceutici S.p.A
April 3, 1995 7:00 AM UTC
Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass. Product: VX-366 small molecule transcription regulator that maintains activation of the fetal gene for hemoglobin F Indication: Beta thalassemia St...